EFFECT OF ADENOVIRUS E3 IMMUNOREGULATORY PROTEIN ON ALLOGENIC TRANSPLANTATION
腺病毒E3免疫调节蛋白对异体移植的影响
基本信息
- 批准号:6105783
- 负责人:
- 金额:$ 22.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-15 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adenoviridae MHC class I antigen NOD mouse diabetes mellitus diabetes mellitus therapy disease /disorder prevention /control genetically modified animals homologous transplantation immediate early protein immunomodulators lymphocyte microorganism immunology nonhuman therapy evaluation pancreatic islet transplantation transplantation immunology tumor necrosis factor alpha
项目摘要
Human adenoviruses (Ads) encode a number of proteins that modulate
the host responses against virus-infected cells. These proteins, whose
genes are clustered in the early region 3 (E3) transcription unit, can (1)
control transport of the class I major histocompatibility complex (MHC)
heavy chain from the endoplasmic reticulum (ER) to the cell surface and
(2) inhibit cytolysis induced by tumor necrosis factor alpha (TNFalpha).
We postulated that the anti-class I MHC and anti-TNF effects of the Ad E3
genes may be used to facilitate allogenic pancreatic beta-cell
transplantation and prevent autoimmune diabetes. Experiments have been
performed in transgenic mice carrying the entire Ad2 E3 transcription
region behind the rat insulin promoter (RIP) to test these hypothesis.
Both tolerization to long-term allogeneic transplantation and prevention
of lymphocytic choriomeningitis virus (LCMV)-induced autoimmune diabetes
have been achieved in the presence of the Ad E3 transgenes expressed in
islets. Encouraged by these initial results, we wish to extend these
observations into new area of investigation by studying the contributions
of individual Ad E3 gene products in the transplantation and LCMV models
as well as introduce the Ad E3 immunoregulatory gene functions into the
islets of nonobese diabetic (NOD) mice. The Ad E3 genes will also be
inserted into a conditionally immortalized and growth controlled murine
beta-cell line for the long term correction of diabetes by allogeneic
transplantation.
人腺病毒(ADS)编码许多蛋白质,这些蛋白质可调节
宿主对感染病毒的细胞做出反应。这些蛋白质,其
基因聚集在早期区域3(E3)转录单位CaN(1)
控制I类主要组织相容性复合体(MHC)的运输
从内质网到细胞表面的重链和
(2)抑制肿瘤坏死因子α诱导的细胞溶解。
我们推测AdE3的抗I类MHC和抗肿瘤坏死因子的作用
基因可能被用来促进同种异体胰岛β细胞
移植和预防自身免疫性糖尿病。实验已经被
在携带完整AD2 E3转录的转基因小鼠中进行
大鼠胰岛素启动子(RIP)后面的区域来验证这些假设。
长期同种异体移植的耐受性与预防
淋巴细胞性脉络膜脑膜炎病毒(LCMV)诱导的自身免疫性糖尿病
在AdE3转基因的存在下实现了
小岛。受到这些初步结果的鼓舞,我们希望延长这些
从研究贡献看新的研究领域
单个Ad E3基因产物在移植和LCMV模型中的应用
以及将AdE3免疫调节基因功能引入到
非肥胖糖尿病(NOD)小鼠的胰岛。AdE3基因也将是
植入有条件永生化和生长受控的小鼠
用于同种异体移植长期纠正糖尿病的β细胞系
移植。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARSHALL S. HORWITZ其他文献
MARSHALL S. HORWITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARSHALL S. HORWITZ', 18)}}的其他基金
Pathogenesis of ELANE-Associated Neutropenia
ELANE 相关中性粒细胞减少症的发病机制
- 批准号:
9011147 - 财政年份:2016
- 资助金额:
$ 22.79万 - 项目类别:
相似海外基金
Elucidating a molecular understanding of ILC2 MHC class I antigen cross priming
阐明 ILC2 MHC I 类抗原交叉引发的分子理解
- 批准号:
486527 - 财政年份:2022
- 资助金额:
$ 22.79万 - 项目类别:
Studentship Programs
Restoring MHC class I antigen presentation to enhance anti-tumour immunity
恢复MHC I类抗原呈递,增强抗肿瘤免疫力
- 批准号:
nhmrc : GNT1164054 - 财政年份:2020
- 资助金额:
$ 22.79万 - 项目类别:
Project Grants
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8996707 - 财政年份:2014
- 资助金额:
$ 22.79万 - 项目类别:
Ubiquitin conjugation and direct MHC class I antigen presentation
泛素结合和直接 MHC I 类抗原呈递
- 批准号:
8880646 - 财政年份:2014
- 资助金额:
$ 22.79万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
9206412 - 财政年份:2014
- 资助金额:
$ 22.79万 - 项目类别:
Subversion of MHC class I antigen presentation by viral immunomodulatory proteins
病毒免疫调节蛋白颠覆 MHC I 类抗原呈递
- 批准号:
8723605 - 财政年份:2014
- 资助金额:
$ 22.79万 - 项目类别:
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
8072956 - 财政年份:2010
- 资助金额:
$ 22.79万 - 项目类别:
The function of the Ubiquitin-Proteasome-System (UPS) in MHC class I antigen processing in target cells and maturing human dendritic cells (hDCs).
泛素蛋白酶体系统 (UPS) 在靶细胞和成熟人树突细胞 (hDC) 中 MHC I 类抗原加工中的功能。
- 批准号:
105348415 - 财政年份:2009
- 资助金额:
$ 22.79万 - 项目类别:
Research Grants
In vivo analysis of the imnportance of proteasome immunosubunits and of PA28 for MHC class I antigen processing, CTL response induction and tumor-virus elimination (A 7)
体内分析蛋白酶体免疫亚基和 PA28 对于 MHC I 类抗原加工、CTL 反应诱导和肿瘤病毒消除的重要性 (A 7)
- 批准号:
5354871 - 财政年份:2002
- 资助金额:
$ 22.79万 - 项目类别:
Collaborative Research Centres
MHC Class I Antigen Presentation in Viral Infections
病毒感染中 MHC I 类抗原呈递
- 批准号:
7991835 - 财政年份:2001
- 资助金额:
$ 22.79万 - 项目类别: